Marco Mazzorana

1.2k total citations
24 papers, 960 citations indexed

About

Marco Mazzorana is a scholar working on Molecular Biology, Materials Chemistry and Organic Chemistry. According to data from OpenAlex, Marco Mazzorana has authored 24 papers receiving a total of 960 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 7 papers in Materials Chemistry and 3 papers in Organic Chemistry. Recurrent topics in Marco Mazzorana's work include Protein Kinase Regulation and GTPase Signaling (7 papers), Enzyme Structure and Function (7 papers) and Protein Structure and Dynamics (6 papers). Marco Mazzorana is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (7 papers), Enzyme Structure and Function (7 papers) and Protein Structure and Dynamics (6 papers). Marco Mazzorana collaborates with scholars based in Italy, United Kingdom and Spain. Marco Mazzorana's co-authors include Lorenzo A. Pinna, Roberto Battistutta, Stefania Sarno, Flavio Meggio, Giorgio Cozza, Stefano Moro, Zygmunt Kazimierczuk, Giuseppe Zanotti, Mario A. Pagano and Giuseppe Zagotto and has published in prestigious journals such as Blood, PLoS ONE and Biochemistry.

In The Last Decade

Marco Mazzorana

24 papers receiving 946 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marco Mazzorana Italy 15 618 238 154 136 120 24 960
Pramod P. Mehta United States 19 547 0.9× 275 1.2× 93 0.6× 108 0.8× 184 1.5× 32 1.0k
Matthew J. Sykes Australia 19 531 0.9× 198 0.8× 121 0.8× 58 0.4× 171 1.4× 44 907
Steven E. Hall United States 20 952 1.5× 574 2.4× 124 0.8× 71 0.5× 126 1.1× 40 1.5k
Derek Barratt United Kingdom 10 606 1.0× 205 0.9× 85 0.6× 40 0.3× 246 2.0× 20 1.0k
E. De Moliner Italy 7 432 0.7× 107 0.4× 105 0.7× 98 0.7× 101 0.8× 7 619
Jacopo Sgrignani Italy 22 611 1.0× 214 0.9× 203 1.3× 120 0.9× 228 1.9× 61 1.2k
Peter M.U. Ung United States 21 1.2k 2.0× 118 0.5× 430 2.8× 160 1.2× 152 1.3× 32 1.6k
Keizo Koya United States 19 627 1.0× 406 1.7× 59 0.4× 115 0.8× 205 1.7× 31 1.2k
Ted W. Johnson United States 18 790 1.3× 395 1.7× 214 1.4× 36 0.3× 156 1.3× 28 1.6k
Fedor N. Novikov Russia 14 348 0.6× 157 0.7× 175 1.1× 70 0.5× 111 0.9× 43 803

Countries citing papers authored by Marco Mazzorana

Since Specialization
Citations

This map shows the geographic impact of Marco Mazzorana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Mazzorana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Mazzorana more than expected).

Fields of papers citing papers by Marco Mazzorana

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Mazzorana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Mazzorana. The network helps show where Marco Mazzorana may publish in the future.

Co-authorship network of co-authors of Marco Mazzorana

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Mazzorana. A scholar is included among the top collaborators of Marco Mazzorana based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Mazzorana. Marco Mazzorana is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pozzi, Cecilia, Anne Vanet, Valeria Francesconi, et al.. (2023). Antitarget, Anti-SARS-CoV-2 Leads, Drugs, and the Drug Discovery–Genetics Alliance Perspective. Journal of Medicinal Chemistry. 66(6). 3664–3702. 23 indexed citations
2.
Mangini, Vincenzo, Elena Rosini, Rocco Caliandro, et al.. (2023). DypB peroxidase for aflatoxin removal: New insights into the toxin degradation process. Chemosphere. 349. 140826–140826. 8 indexed citations
3.
Mazzorana, Marco, Stefano Mangani, Elena Petricci, et al.. (2022). Structural Characterization of Human Heat Shock Protein 90 N-Terminal Domain and Its Variants K112R and K112A in Complex with a Potent 1,2,3-Triazole-Based Inhibitor. International Journal of Molecular Sciences. 23(16). 9458–9458. 5 indexed citations
4.
Mazzorana, Marco, et al.. (2022). Structural Basis of Parasitic HSP90 ATPase Inhibition by Small Molecules. Pharmaceuticals. 15(11). 1341–1341. 1 indexed citations
5.
Mazzorana, Marco, et al.. (2020). A comprehensive approach to X-ray crystallography for drug discovery at a synchrotron facility — The example of Diamond Light Source. Drug Discovery Today Technologies. 37. 83–92. 10 indexed citations
6.
Mazzorana, Marco & Thomas Sørensen. (2019). Calcium-Induced Protein Folding in Calumenin and Calmodulin. Methods in molecular biology. 1929. 517–537. 4 indexed citations
7.
8.
Sánchez-Weatherby, Juan, James Sandy, Halina Mikolajek, et al.. (2018). VMXi: a fully automated, fully remote, high-flux in situ macromolecular crystallography beamline. Journal of Synchrotron Radiation. 26(1). 291–301. 39 indexed citations
9.
Lobley, Carina M. C., James Sandy, Juan Sánchez-Weatherby, et al.. (2016). A generic protocol for protein crystal dehydration using the HC1b humidity controller. Acta Crystallographica Section D Structural Biology. 72(5). 629–640. 14 indexed citations
10.
Mazzorana, Marco, Rohanah Hussain, & Thomas Sørensen. (2016). Ca-Dependent Folding of Human Calumenin. PLoS ONE. 11(3). e0151547–e0151547. 15 indexed citations
11.
Mazzorana, Marco, Juan Sánchez-Weatherby, James Sandy, Carina M. C. Lobley, & Thomas Sørensen. (2014). An evaluation of adhesive sample holders for advanced crystallographic experiments. Acta Crystallographica Section D Biological Crystallography. 70(9). 2390–2400. 5 indexed citations
12.
Zonta, Francesca, Mario A. Pagano, Livio Trentin, et al.. (2013). Lyn-mediated procaspase 8 dimerization blocks apoptotic signaling in B-cell chronic lymphocytic leukemia. Blood. 123(6). 875–883. 27 indexed citations
13.
Pastor, Joaquı́n, Julen Oyarzábal, Rosa M. Álvarez, et al.. (2012). Hit to lead evaluation of 1,2,3-triazolo[4,5-b]pyridines as PIM kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(4). 1591–1597. 35 indexed citations
14.
Mazzorana, Marco, Guillermo Montoya, & Gulnahar B. Mortuza. (2011). The Centrosome: A Target for Cancer Therapy. Current Cancer Drug Targets. 11(5). 600–612. 14 indexed citations
15.
Sarno, Stefania, Marco Mazzorana, Ryan Traynor, et al.. (2011). Structural features underlying the selectivity of the kinase inhibitors NBC and dNBC: role of a nitro group that discriminates between CK2 and DYRK1A. Cellular and Molecular Life Sciences. 69(3). 449–460. 26 indexed citations
16.
Mazzorana, Marco, Mario A. Pagano, Giorgio Arrigoni, et al.. (2010). The pleiotropic protein kinase CK2 phosphorylates HTLV-1 Tax protein in vitro, targeting its PDZ-binding motif. Virus Genes. 41(2). 149–157. 19 indexed citations
17.
Mazzorana, Marco, Lorenzo A. Pinna, & Roberto Battistutta. (2008). A structural insight into CK2 inhibition. Molecular and Cellular Biochemistry. 316(1-2). 57–62. 41 indexed citations
18.
Battistutta, Roberto, Marco Mazzorana, Laura Cendron, et al.. (2007). The ATP‐Binding Site of Protein Kinase CK2 Holds a Positive Electrostatic Area and Conserved Water Molecules. ChemBioChem. 8(15). 1804–1809. 91 indexed citations
19.
Sarno, Stefania, Maria Ruzzene, Mario A. Pagano, et al.. (2005). Development and exploitation of CK2 inhibitors. Molecular and Cellular Biochemistry. 274(1-2). 69–76. 82 indexed citations
20.
Battistutta, Roberto, Marco Mazzorana, Stefania Sarno, et al.. (2005). Inspecting the Structure-Activity Relationship of Protein Kinase CK2 Inhibitors Derived from Tetrabromo-Benzimidazole. Chemistry & Biology. 12(11). 1211–1219. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pramod P. Mehta Breakdown of academic impact, for papers by Matthew J. Sykes Breakdown of academic impact, for papers by Steven E. Hall Breakdown of academic impact, for papers by Derek Barratt Breakdown of academic impact, for papers by E. De Moliner Breakdown of academic impact, for papers by Jacopo Sgrignani Breakdown of academic impact, for papers by Peter M.U. Ung Breakdown of academic impact, for papers by Keizo Koya Breakdown of academic impact, for papers by Ted W. Johnson Breakdown of academic impact, for papers by Fedor N. Novikov
Rankless by CCL
2026